Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Effect of TMS on PTSD Biomarkers

A legfontosabb adatok

Ki végzi
Emory University
Hol
Atlanta (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
50 fő vett részt
Kezdés
2021. febr. 15.
Befejezés
2025. szept. 28.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport színlelt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Transcranial Magnetic Stimulation (TMS)
  • Sham Transcranial Magnetic Stimulation (TMS)
A regiszteradat frissítve
2026. június 1.

Ki vehet részt

Életkor
18 év – 65 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 14 feltétel megnézéseKevesebb

Ki vehet részt

  • Men and women 18-65 years of age
  • Meet for partial PTSD, defined as 3 out of 4 symptom clusters always including cluster E (alterations in arousal and reactivity) according to the DSM-5 criteria using the Clinician-Administered PTSD Scale (CAPS-5)
  • Capable and willing to provide informed consent
  • Able to adhere to the treatment schedule

Ki nem vehet részt

  • Unstable psychotropic medication status. Participants taking psychotropic medications (i.e.,antidepressants, antipsychotics, benzodiazepines and anticonvulsants, etc.) can be enrolled in the study as long as medication type and dose has been stable for at least 6 weeks, and additionally, medication type or dose does not change during the course of the study
  • Current substance abuse or dependence as indicated by a score of 6 or higher on the Drug Abuse Screening Test (DAST)
  • Currently participating in another clinical study or enrolled in another clinical study within 30 days prior to this study or started (new) treatment for PTSD within 3 months prior to this study
  • Previously treated with TMS
  • Lifetime diagnosis of psychotic disorder or bipolar I disorder per diagnostic interview
  • Diagnosed with the following conditions: a neurological disorder, including a history of seizures, cerebrovascular disease, primary or secondary tumors in CNS, stroke, cerebral aneurysm or movement disorder or any lifetime history of loss of consciousness for more than 5 minutes due to head injury
  • History of cranial surgery, metallic particles in the eye or head (exclusive of mouth), implanted cardiac pacemaker or any intra-cardiac lines, implanted neurostimulators, intra-cranial implants (e.g., aneurysm clips, shunts, stimulators, cochlear implants, or electrodes) or implanted medical pumps
  • Current alcohol abuse or dependence as indicated by a score of 8 or higher on the Alcohol Use Disorder Identification Test (AUDIT)
  • Being pregnant or a positive pregnancy test at the beginning of each TMS treatment week for sexually active women of childbearing age who are on reliable birth control
  • Having active suicidal intent or plan as defined by a positive answer to questions 4 and/or 5 on the Columbia-Suicide Severity Rating Scale (C-SSRS): Screening version; or in the clinician's opinion, is likely to attempt suicide within the next six months

Helyszínek itt: Egyesült Államok

  • Grady HospitalAtlanta, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The study will (1) assess feasibility of a TMS treatment in an underserved population; (2) determine if this TMS treatment protocol improves PTSD symptoms and biological markers of PTSD such as brain functioning and startle responses; (3) define new brain targets for future TMS studies; (4) provide the first data for individual differences, which will help personalize treatment for PTSD patients; (5) improve knowledge of the neurobiology of PTSD and treatment response.

A vizsgálat 2 csoportja

  • Transcranial Magnetic Stimulation (TMS)A vizsgált kezelés

    TMS is a noninvasive treatment that uses magnetic fields to induce a small electric current in specific brain regions.

  • Sham Transcranial Magnetic Stimulation (TMS)Színlelt kezelés, összehasonlításként

    Sessions of Sham Transcranial Magnetic Stimulation (TMS) will be conducted.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Effect of Transcranial Magnetic Stimulation (TMS) on PTSD Neuroimaging and Psychophysiological Biomarkers
A regiszteradat frissítve
2026. június 1.